Tuesday, February 18, 2020

Peripheral Intravenous Vasopressors

R.E.B.E.L.Crit - February 17, 2020 - By Salim Rezaie 
"Author Conclusion: “We found an overall incidence of extravasation events of 4% in patients receiving vasopressors through a PVL that were not managed under a strict safety protocol. None of these events were severe enough to require the use of an antidote or surgical intervention, and in 7 of the 8 cases vasopressors were resumed at a separate peripheral site.”
Clinical Take Home Point: This study, although retrospective and single center (serious methodological limitations) adds to the knowledge of using vasopressors through peripheral IVs. The documented risk for extravasation injury of 4% in this study is similar to extravasation rates seen in prior publications (i.e. 3 – 6%) and there were zero cases of limb ischemia or necrosis requiring surgical intervention. Hypothetically, the extravasation rate can be further reduced by implementation of a strict observation protocols and extravasation management protocols."